Alere Inc., a Waltham company that makes medical diagnostic products, reported net revenue of $739.2 million for the first quarter of 2013, compared with revenue of $671.1 million for the first quarter of 2012.
In a Thursday press release, the company also reported net income of $7.2 million attributable to common stockholders of Alere, and respective net income per diluted common share of $0.09, for the first quarter of 2013, compared with a net loss of $4.1 million attributable to common stockholders of Alere, and respective net loss per diluted common share of $0.05, for the first quarter of 2012.
According to Alere, its products and services enable “individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions.”
Ron Zwanziger, Alere’s chairman, chief executive, and president, commented on the quarterly results in a statement.
‘‘I’m pleased to report another quarter of progress across the organization,” he said. “With our company formation substantially complete, and the areas of pressure with Triage and Health Information Solutionsshowing signs of stability, we were able to take key steps to drive improved operating expense leverage in the first quarter.’’